National Health Care (NHC) Stock
Operator of skilled nursing and assisted living facilities. Here's the price, business snapshot, and what's worth knowing about National Health Care in August 2026.
National HealthCare Corporation (NHC) is a US-based operator of skilled nursing, assisted living and post-acute rehabilitation facilities. With a market capitalisation of about $1.88bn, NHC’s results are sensitive to occupancy levels, the mix of Medicare/Medicaid versus private-pay residents, and reimbursement rates set by government programmes. Investors typically watch metrics such as same-facility occupancy, payer mix, and revenue per patient day, alongside labour costs and regulatory compliance. Strengths can include steady demand from an ageing population and potential for operational improvements; threats include reimbursement cuts, staffing shortages and inspection or licencing issues. Financial performance can be cyclical and variable, so prospective investors should review the company’s recent filings, management commentary and industry trends. This is general educational information only and not personal advice — investments can fall as well as rise, and suitability depends on individual circumstances.
Sixth Month Growth Performance
Stock Performance Snapshot
Financial Health
National HealthCare Corporation is performing well with strong cash flow and solid revenues.
Dividend
National HealthCare Corporation's dividend yield of 1.53% is considered below average, which may not attract income-focused investors. If you invested $1000 you would be paid $15.30 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Occupancy & Revenue
Occupancy rates and payer mix strongly influence short-term revenue and margins; small changes can materially affect results, so monitor these metrics.
Labour & Costs
Staffing levels and wage inflation are major cost pressures for care providers and can compress margins if not managed alongside pricing and efficiency.
Regulation & Reimbursement
Reimbursement policy and inspection standards shape profitability; regulatory shifts or funding changes can have significant financial impact.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
